1 |
AL SOMALI Z, HAMADANI M, KHARFAN-DABAJA M, et al. Enteropathy-associated T cell lymphoma[J]. Curr Hematol Malig Rep, 2021, 16(2): 140-147.
|
2 |
张旭, 董菲, 田磊, 等. 单形性嗜上皮性肠道T细胞淋巴瘤11例临床分析[J]. 中国微创外科杂志, 2022, 22(3): 232-236.
|
|
ZHANG X, DONG F, TIAN L, et al. Clinical analysis of 11 cases of monomorphic epitheliotropic intestinal T-cell lymphoma[J]. Chinese Journal of Minimally Invasive Surgery, 2022, 22(3): 232-236.
|
3 |
JAFFE E S. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research[J]. Hematology Am Soc Hematol Educ Program, 2009: 523-531.
|
4 |
SWERDLOW S H, CAMPO E, PILERI S A, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms[J]. Blood, 2016, 127(20): 2375-2390.
|
5 |
TOMITA S, KIKUTI Y Y, CARRERAS J, et al. Genomic and immunohistochemical profiles of enteropathy-associated T-cell lymphoma in Japan[J]. Mod Pathol, 2015, 28(10): 1286-1296.
|
6 |
ONDREJKA S, JAGADEESH D. Enteropathy-associated T-cell lymphoma[J]. Curr Hematol Malig Rep, 2016, 11(6): 504-513.
|
7 |
杨晓俊, 候宁, 史传兵. 单形性亲上皮性肠道T细胞淋巴瘤的病理学特征及MATK表达的诊断价值[J]. 东南大学学报(医学版), 2022, 41(2): 250-255.
|
|
YANG X J, HOU N, SHI C B. Pathological features and diagnostic value of the expression of MATK in monomorphic epitheliotropic intestinal T-cell lymphoma[J]. Journal of Southeast University (Medical Science Edition), 2022, 41(2): 250-255.
|
8 |
MONTES-MORENO S, KING R L, OSCHLIES I, et al. Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas[J]. Virchows Arch, 2020, 476(5): 667-681.
|
9 |
SABATTINI E, BACCI F, SAGRAMOSO C, et al. WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview[J]. Pathologica, 2010, 102(3): 83-87.
|
10 |
GALE J, SIMMONDS P D, MEAD G M, et al. Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center[J]. J Clin Oncol, 2000, 18(4): 795-803.
|
11 |
HORWITZ S M, ANSELL S, AI W Z, et al. NCCN guidelines insights: T-cell lymphomas, version 1.2021[J]. J Natl Compr Canc Netw, 2020, 18(11): 1460-1467.
|
12 |
YI J H, LEE G W, DO Y R, et al. Multicenter retrospective analysis of the clinicopathologic features of monomorphic epitheliotropic intestinal T-cell lymphoma[J]. Ann Hematol, 2019, 98(11): 2541-2550.
|
13 |
SIENIAWSKI M, ANGAMUTHU N, BOYD K, et al. Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation[J]. Blood, 2010, 115(18): 3664-3670.
|
14 |
赵东陆, 马军. T细胞淋巴瘤治疗进展[J]. 白血病·淋巴瘤, 2017, 26(8): 449-451.
|
|
ZHAO D L, MA J. Progress of T-cell lymphoma treatment[J]. Journal of Leukemia and Lymphoma, 2017, 26(8): 449-451.
|
15 |
VOORHEES T J, GHOSH N, GROVER N, et al. Long-term remission in multiply relapsed enteropathy-associated T-cell lymphoma following CD30 CAR T-cell therapy[J]. Blood Adv, 2020, 4(23): 5925-5928.
|
16 |
宋双双, 于澜, 周晓明, 等. 原发性肠道T细胞淋巴瘤CT小肠造影的影像特点及其诊断价值[J]. 中国医学影像技术, 2017, 33(7): 1010-1013.
|
|
SONG S S, YU L, ZHOU X M, et al. Diagnostic value and characteristics of CT enterography in primary intestinal T-cell lymphoma[J]. Chinese Journal of Medical Imaging Technology, 2017, 33(7): 1010-1013.
|